Osaic Holdings
IMDX

Osaic Holdings’s Insight Molecular Diagnostics IMDX Stock Holding History

Osaic Holdings’s Portfolio IMDX Stock Details IMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$231K Buy
39,136
+15,001
+62% +$74K ﹤0.01% 4306
2026
Q1 		$79.2K Sell
24,135
-1
-0% -$6 ﹤0.01% 4853
2025
Q4 		$181K Buy
24,136
+12,920
+115% +$72.9K ﹤0.01% 4234
2025
Q3 		$29.3K Buy
11,216
+9,953
+788% +$28.1K ﹤0.01% 5668
2025
Q2 		$3.81K Hold
1,263
– – ﹤0.01% 6692
2025
Q1 		$3.86K Buy
1,263
+1,081
+594% +$2.92K ﹤0.01% 6303
2024
Q4 		$431 Sell
182
-898
-83% -$2.44K ﹤0.01% 7050
2024
Q3 		$3.08K Sell
1,080
-47
-4% -$146 ﹤0.01% 6426
2024
Q2 		$3.32K Buy
1,127
+1,030
+1,062% +$2.83K ﹤0.01% 6375
2024
Q1 		$284 Hold
97
– – ﹤0.01% 6912
2023
Q4 		$242 Sell
97
-1,169
-92% -$3.6K ﹤0.01% 7004
2023
Q3 		$3.95K Buy
1,266
+43
+4% +$160 ﹤0.01% 6373
2023
Q2 		$5.62K Hold
1,223
– – ﹤0.01% 6259
2023
Q1 		$8.66K Hold
1,223
– – ﹤0.01% 6055
2022
Q4 		$7.93K Buy
1,223
+1,081
+761% +$11.9K ﹤0.01% 6087
2022
Q3 		$2K Hold
142
– – ﹤0.01% 6802
2022
Q2 		$3K Hold
142
– – ﹤0.01% 6742
2022
Q1 		$19K Hold
142
– – ﹤0.01% 5733
2021
Q4 		$6K Hold
142
– – ﹤0.01% 6551
2021
Q3 		$10K Hold
142
– – ﹤0.01% 6198
2021
Q2 		$16K Sell
142
-503
-78% -$49.1K ﹤0.01% 5796
2021
Q1 		$67K Buy
645
+593
+1,140% +$56.3K ﹤0.01% 4662
2020
Q4 		$2K Buy
52
+35
+206% +$1.28K ﹤0.01% 6086
2020
Q3 		$0 Buy
17
+3
+21% +$86 ﹤0.01% 6350
2020
Q2 		$0 Hold
14
– – ﹤0.01% 6264
2020
Q1 		$1K Buy
+14
New +$686 ﹤0.01% 5888

Other funds holding IMDX

BC
Broadwood Capital New York $1.91B AUM 44.39% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
FOR
Family Office Research Bethesda, Maryland $267M AUM 27.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Osaic Holdings's IMDX Position: Q2 2026 in Review

Osaic Holdings increased its Insight Molecular Diagnostics (IMDX) stake by 62% in Q2 2026, buying an estimated $74K and bringing the position to 39,136 shares worth $231K. The position accounts for ﹤0.01% of the portfolio, ranked #4306.

Osaic Holdings first reported a position in IMDX in Q1 2020 and has held it in 26 quarters since. 40 funds tracked by Wall St. Rank hold IMDX as of Q2 2026.

  • Osaic Holdings held 39,136 shares of Insight Molecular Diagnostics worth $231K as of Q2 2026.
  • Osaic Holdings bought 15,001 Insight Molecular Diagnostics shares in Q2 2026, an estimated $74K.
  • Insight Molecular Diagnostics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #4306 holding.
  • Osaic Holdings first reported a position in Insight Molecular Diagnostics in Q1 2020 and has held it in 26 quarters since.
  • 40 funds tracked by Wall St. Rank held Insight Molecular Diagnostics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.